Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05209633Phase 2Completed
A Phase 2 trial of tiepifengdou granules in chronic atrophic gastritis (CAG), sponsored by The Chinese University of Hong Kong. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05209633.